Corrigendum to “PEGylated ofloxacin nanoparticles render strong antibacterial activity against many clinically important human pathogens” [Colloids Surf. B: Biointerfaces 132 (2015) 62–70]

Publication date: 1 May 2019Source: Colloids and Surfaces B: Biointerfaces, Volume 177Author(s): Gregory Marslin, Ann Mary Revina, Vinoth Kumar Megraj Khandelwal, Krishnamoorthy Balakumar, Caroline J. Sheeba, Gregory Franklin
Source: Colloids and Surfaces B: Biointerfaces - Category: Biochemistry Source Type: research